Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sandoz
Sandoz
Sandoz in oncology biosimilar deal with China’s Bio-Thera
Biopharma Reporter
Wed, 09/8/21 - 11:15 am
Sandoz
Novartis
biosimilars
China
BAT1706
Bio-Thera Solutions
Novartis' Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe
Fierce Pharma
Tue, 05/18/21 - 11:01 am
Novartis
Sandoz
generics
Europe
drug manufacturing
Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein
Fierce Pharma
Mon, 05/17/21 - 10:59 pm
Novartis
Sandoz
generics
Supreme Court
Amgen
Embrel
biosimilar
Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity
Endpoints
Tue, 03/9/21 - 10:49 am
Novartis
generics
Sandoz
FDA
Aubagio
multiple sclerosis
MS
GlaxoSmithKline to shut down antibiotics production, cut 300 jobs in wake of Novartis buyout
Fierce Pharma
Fri, 02/12/21 - 11:09 am
GSK
Novartis
Sandoz
layoffs
antibiotics
drug manufacturing
Novartis' Sandoz doubles down on antibiotics with $500M deal for GSK brands
Fierce Pharma
Thu, 02/11/21 - 10:26 pm
Novartis
Sandoz
generics
antibiotics
Sandoz working to overcome barriers to greater biosimilars uptake in US
Biopharma Reporter
Mon, 09/21/20 - 10:55 am
Sandoz
biosimilars
Novartis
Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing
BioPharma Dive
Mon, 07/27/20 - 11:05 pm
Novartis
Sandoz
Europe
antibiotics
drug manufacturing
Novartis to provide 'no profit' COVID-19 drugs to low income countries
Reuters
Thu, 07/16/20 - 11:00 am
Novartis
Sandoz
non-profits
developing countries
generics
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report
Fierce Pharma
Mon, 05/18/20 - 10:56 pm
Teva Pharmaceutical
price fixing
generics
COVID-19
Sandoz
JNJ
Novartis
Taro Pharmaceuticals
Novartis cancels $1B sale of generics after antitrust concerns forced delays
Endpoints
Thu, 04/2/20 - 10:49 am
Novartis
generics
Sandoz
antitrust
Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe
BioSpace
Tue, 03/3/20 - 10:55 am
Sandoz
generics
Novartis
antitrust
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Fierce Pharma
Thu, 02/27/20 - 10:39 am
Sandoz
generics
antibiotics
COVID-19
coronaviruses
Former Novartis exec pleads guilty to generic price fixing
Endpoints
Tue, 02/18/20 - 10:25 am
Novartis
Sandoz
price fixing
generics
DOJ
Sandoz Completes Acquisition of Aspen's Japanese Operations
BioSpace
Sat, 02/1/20 - 11:49 pm
Sandoz
Aspen Global
Japan
M&A
Novartis
Novartis' Sandoz loses bid to break United Therapeutics' exclusive device deal for Remodulin
Fierce Pharma
Thu, 01/30/20 - 09:17 pm
Novartis
Sandoz
United Therapeutics
Remodulin
Novartis' Generics Unit to Buy Aspen's Japanese Operations
Yahoo/Zacks.com
Mon, 11/11/19 - 10:47 am
Novartis
generics
Sandoz
M&A
Japan
Aspen Pharmacare
Aspen Global
Novartis takes a step back from marketing Pear prescription digital therapeutics
Biopharma Dive
Wed, 10/16/19 - 06:57 pm
Novartis
Sandoz
Pear Therapeutics
digital therapeutics
opioid abuse
Why Bausch Health Companies Stock Sank Today
Motley Fool
Tue, 10/1/19 - 11:01 pm
Bausch Health
Novartis
Sandoz
Xifaxan
patents
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
Pharmaforum
Tue, 09/3/19 - 10:30 am
Novartis
Sandoz
generics
biosimilars
Tysabri
Polpharma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »